Cargando…
A survey of the European Society of Clinical Pharmacy members’ research involvement, and associated enablers and barriers
Background Building research capacity of European Society of Clinical Pharmacy (ESCP) members aligns to the organisation’s aim of advancing research. Objective To determine members’ aspirations and needs in research training and practice, and to explore ways in which ESCP could provide support. Sett...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476984/ https://www.ncbi.nlm.nih.gov/pubmed/32430883 http://dx.doi.org/10.1007/s11096-020-01054-9 |
_version_ | 1783579801064308736 |
---|---|
author | Stewart, Derek Paudyal, Vibhu Cadogan, Cathal Hazen, Ankie Okuyan, Betul Lutters, Monika Henman, Martin Fialová, Daniella |
author_facet | Stewart, Derek Paudyal, Vibhu Cadogan, Cathal Hazen, Ankie Okuyan, Betul Lutters, Monika Henman, Martin Fialová, Daniella |
author_sort | Stewart, Derek |
collection | PubMed |
description | Background Building research capacity of European Society of Clinical Pharmacy (ESCP) members aligns to the organisation’s aim of advancing research. Objective To determine members’ aspirations and needs in research training and practice, and to explore ways in which ESCP could provide support. Setting ESCP’s international membership. Method Cross-sectional survey of members in 2018, followed by focus groups with samples of respondents attending an ESCP symposium. Survey items were: research activities; interests, experience and confidence; and Likert statements on research conduct. Principal component analysis (PCA) clustering of Likert statements from a previous study was used, with scores for each component calculated. Focus groups discussed barriers to research and how ESCP could provide support. Data analysis involved collating and comparing all themes. Main outcome measures Research interest, experience and confidence; attitudinal items; barriers to research; ESCP support. Results The response rate was 16.7% (83/499), with 89.2% (n = 74) involved in research and 79.5% (n = 66) publishing research in the preceding 2 years. While overwhelmingly positive, responses were more positive for research interest than experience or confidence. PCA component scores (support/opportunities, motivation/outcomes, and roles/characteristics) were positive. Thirteen members participated in focus groups, identifying barriers of: insufficient collaboration; lack of knowledge, skills, training; unsupportive environment; insufficient time; and limited resources. ESCP could support through mentorship, collaboration, education and funding. Conclusion Study participants were highly active, interested, experienced, confident and positive regarding research. There is an opportunity for ESCP to harness these activities and provide support in the form of mentoring, education and training, and facilitating collaboration. |
format | Online Article Text |
id | pubmed-7476984 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-74769842020-09-21 A survey of the European Society of Clinical Pharmacy members’ research involvement, and associated enablers and barriers Stewart, Derek Paudyal, Vibhu Cadogan, Cathal Hazen, Ankie Okuyan, Betul Lutters, Monika Henman, Martin Fialová, Daniella Int J Clin Pharm Research Article Background Building research capacity of European Society of Clinical Pharmacy (ESCP) members aligns to the organisation’s aim of advancing research. Objective To determine members’ aspirations and needs in research training and practice, and to explore ways in which ESCP could provide support. Setting ESCP’s international membership. Method Cross-sectional survey of members in 2018, followed by focus groups with samples of respondents attending an ESCP symposium. Survey items were: research activities; interests, experience and confidence; and Likert statements on research conduct. Principal component analysis (PCA) clustering of Likert statements from a previous study was used, with scores for each component calculated. Focus groups discussed barriers to research and how ESCP could provide support. Data analysis involved collating and comparing all themes. Main outcome measures Research interest, experience and confidence; attitudinal items; barriers to research; ESCP support. Results The response rate was 16.7% (83/499), with 89.2% (n = 74) involved in research and 79.5% (n = 66) publishing research in the preceding 2 years. While overwhelmingly positive, responses were more positive for research interest than experience or confidence. PCA component scores (support/opportunities, motivation/outcomes, and roles/characteristics) were positive. Thirteen members participated in focus groups, identifying barriers of: insufficient collaboration; lack of knowledge, skills, training; unsupportive environment; insufficient time; and limited resources. ESCP could support through mentorship, collaboration, education and funding. Conclusion Study participants were highly active, interested, experienced, confident and positive regarding research. There is an opportunity for ESCP to harness these activities and provide support in the form of mentoring, education and training, and facilitating collaboration. Springer International Publishing 2020-05-19 2020 /pmc/articles/PMC7476984/ /pubmed/32430883 http://dx.doi.org/10.1007/s11096-020-01054-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Stewart, Derek Paudyal, Vibhu Cadogan, Cathal Hazen, Ankie Okuyan, Betul Lutters, Monika Henman, Martin Fialová, Daniella A survey of the European Society of Clinical Pharmacy members’ research involvement, and associated enablers and barriers |
title | A survey of the European Society of Clinical Pharmacy members’ research involvement, and associated enablers and barriers |
title_full | A survey of the European Society of Clinical Pharmacy members’ research involvement, and associated enablers and barriers |
title_fullStr | A survey of the European Society of Clinical Pharmacy members’ research involvement, and associated enablers and barriers |
title_full_unstemmed | A survey of the European Society of Clinical Pharmacy members’ research involvement, and associated enablers and barriers |
title_short | A survey of the European Society of Clinical Pharmacy members’ research involvement, and associated enablers and barriers |
title_sort | survey of the european society of clinical pharmacy members’ research involvement, and associated enablers and barriers |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476984/ https://www.ncbi.nlm.nih.gov/pubmed/32430883 http://dx.doi.org/10.1007/s11096-020-01054-9 |
work_keys_str_mv | AT stewartderek asurveyoftheeuropeansocietyofclinicalpharmacymembersresearchinvolvementandassociatedenablersandbarriers AT paudyalvibhu asurveyoftheeuropeansocietyofclinicalpharmacymembersresearchinvolvementandassociatedenablersandbarriers AT cadogancathal asurveyoftheeuropeansocietyofclinicalpharmacymembersresearchinvolvementandassociatedenablersandbarriers AT hazenankie asurveyoftheeuropeansocietyofclinicalpharmacymembersresearchinvolvementandassociatedenablersandbarriers AT okuyanbetul asurveyoftheeuropeansocietyofclinicalpharmacymembersresearchinvolvementandassociatedenablersandbarriers AT luttersmonika asurveyoftheeuropeansocietyofclinicalpharmacymembersresearchinvolvementandassociatedenablersandbarriers AT henmanmartin asurveyoftheeuropeansocietyofclinicalpharmacymembersresearchinvolvementandassociatedenablersandbarriers AT fialovadaniella asurveyoftheeuropeansocietyofclinicalpharmacymembersresearchinvolvementandassociatedenablersandbarriers AT stewartderek surveyoftheeuropeansocietyofclinicalpharmacymembersresearchinvolvementandassociatedenablersandbarriers AT paudyalvibhu surveyoftheeuropeansocietyofclinicalpharmacymembersresearchinvolvementandassociatedenablersandbarriers AT cadogancathal surveyoftheeuropeansocietyofclinicalpharmacymembersresearchinvolvementandassociatedenablersandbarriers AT hazenankie surveyoftheeuropeansocietyofclinicalpharmacymembersresearchinvolvementandassociatedenablersandbarriers AT okuyanbetul surveyoftheeuropeansocietyofclinicalpharmacymembersresearchinvolvementandassociatedenablersandbarriers AT luttersmonika surveyoftheeuropeansocietyofclinicalpharmacymembersresearchinvolvementandassociatedenablersandbarriers AT henmanmartin surveyoftheeuropeansocietyofclinicalpharmacymembersresearchinvolvementandassociatedenablersandbarriers AT fialovadaniella surveyoftheeuropeansocietyofclinicalpharmacymembersresearchinvolvementandassociatedenablersandbarriers |